Document is current
Any future updates will be listed below
-
Authors
Esapa, Benjamina
Liu, Yi
Chenoweth, Alicia M.
Stoker, Katie
Łabędź, Natalia
Romero-Clavijo, Pablo
Ilieva, Kristina M.
Trendell, Jennifer
Navarro-Llinas, Blanca
Suriawinata, Erin
Butcher, Tobias
Wang, Ning
Grandits, Melanie
Palhares, Lais C. G. F.
McCraw, Alexandra
Crescioli, Silvia
Johansson, Annelie
Irshad, Sheeba
Grigoriadis, Anita
Gazinska, Patrycja
Tsoka, Sophia
Chudasama, Vijay
Baker, James R.
Tutt, Andrew N. J.
Cheung, Anthony
Thurston, David E.
Karagiannis, Sophia N.
-
Funding
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/T008709/1)
Biotechnology and Biological Sciences Research Council (BB/Y002180/1)
Biotechnology and Biological Sciences Research Council (BB/Y002180/1)
Biotechnology and Biological Sciences Research Council (BB/Y002180/1)
Biotechnology and Biological Sciences Research Council (BB/Y002180/1)
Biotechnology and Biological Sciences Research Council (BB/T008709/1)
Biotechnology and Biological Sciences Research Council (BB/T008709/1)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
Breast Cancer Now (147; KCL-BCN-Q3)
British Skin Foundation (006/R/22)
British Skin Foundation (006/R/22)
British Skin Foundation (006/R/22)
Cancer Research UK City of London Centre (C7893/A31530)
Cancer Research UK City of London Centre (C7893/A31530)
King’s Health Partners Centre for Translational Medicine
Worldwide Cancer Research (24-0087)
Worldwide Cancer Research (24-0087)
- License Information
-
More Information
Article History
Received: 31 August 2025
Accepted: 16 February 2026
First Online: 7 March 2026
Competing interests
: S.N.K. is the founder and shareholder of Epsilogen Ltd. S.N.K., A.M.C., and A.C. declare patents on antibodies for cancer. D.E.T. is a co-founder of Pheon Therapeutics Ltd. The authors declare no pending patents. The other authors do not declare any competing interests.
